MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1484/001  Supemtek   
EU/1/20/1484/002  Supemtek   
EU/1/20/1484/003  Supemtek   
EU/1/20/1484/004  Supemtek   
EU/1/20/1484/005  Supemtek   
EU/1/20/1484/006  Supemtek   
--¹ 
--¹ 
--¹ 
--¹ 
--¹ 
--¹ 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Intramuscular use  Pre-filled syringe 
0.5 ml 
1 pre-filled syringe  
(glass) 
Intramuscular use  Pre-filled syringe 
0.5 ml 
(glass) 
Intramuscular use  Pre-filled syringe 
0.5 ml 
(glass) 
Intramuscular use  Pre-filled syringe 
0.5 ml 
Intramuscular use  Pre-filled syringe 
0.5 ml 
(glass) 
(glass) 
Intramuscular use  Pre-filled syringe 
0.5 ml 
(glass) 
1 pre-filled syringe 
+ 1 needle  
5 pre-filled syringes  
5 pre-filled syringes 
+ 5 needles  
10 pre-filled 
syringes  
10 pre-filled 
syringes + 10 
needles  
--¹ 
--1 
One dose (0.5 mL) contains: 
Influenza virus haemagglutinin (HA) proteins, of the following strains*: 
A/XXXXXX (H1N1) 
A/XXXXXX (H3N2) 
B/XXXXXX 
B/XXXXXX 
45 micrograms HA 
45 micrograms HA 
            45 micrograms HA 
            45 micrograms HA 
produced by recombinant DNA technology using a baculovirus expression system in a continuous insect cell line that is derived from Sf9 cells of 
* 
the fall armyworm, Spodoptera frugiperda. 
 
 
 
  
 
 
 
 
 
 
